GlaxoSmithKline Phar Dividend yield

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
   INR per share 
 Price  3,314.95
 Dividend  50.06
 Earnings  44.86
 Cash-flow  0.00
 Book value  199.70
 Equity  207.69

GlaxoSmithKline Phar is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. GlaxoSmithKline Phar is a company from India, and his stocks are publicly traded.

GlaxoSmithKline Phar paid a total dividend of 4,255 million INR last year, for a market value of 281,771 millions (Market Cap 67,389 millions). Dividend per share of GlaxoSmithKline Phar is 50.06 INR, and his stock market price 3,314.95 INR.

According to the chart below, where dividend yield is displayed, GlaxoSmithKline Phar has a dividend yield of 1.51%, which is lower than the amount offered by the market average , but bigger than Health Care industry. Dividend yields are similar among companies from the same industry, so it is a positive sign for the company.

In addition, you should compare GlaxoSmithKline Phar dividend yield with other Pharmaceuticals and Biotechnology companies or firms from India.

Dividend yield of GlaxoSmithKline Phar

GlaxoSmithKline Phar Dividend Payout

About the ability of GlaxoSmithKline Phar to maintain his current dividend of INR 50.06 per share, an amount that accounts for 1.51%, we should study its payout ratio both on earnings and on cash-flows (see chart below). GlaxoSmithKline Phar payout on ernings is currently 111.59%, which is higher than the market average, and companies of Health Care industry, which are 40.42% and 35.37% respectively. Both figures show that GlaxoSmithKline Phar can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of GlaxoSmithKline Phar is INR 0.00 per share, which is lower than the dividend per share paid by the company of INR 50.06, so the company does not generate enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of GlaxoSmithKline Phar, compared againt world market average, India companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

GlaxoSmithKline Phar payout

GlaxoSmithKline Phar Stock performance

Finally, last moth GlaxoSmithKline Phar showed a return of -4.90% compared to a worldwide 4.85% average, and a 4.63% of Health Care firms. Over the last year, the company obtained a -5.90% versus a worldwide performance of a -2.38%. More detailed information can be seen in the following graph for India and Pharmaceuticals and Biotechnology firms.

GlaxoSmithKline Phar stock and market return

Next companies

GlaxoSmithKlinensume. India. Consumer Goods.

Glencore. UK. Basic Materials.

Glenmark Pharmaceuti. India. Health Care.

Global Brands Group. Hong-Kong. Consumer Goods.

Global Logistic Prop. Singapore. Financials.

Global Mediacom Tbk. Indonesia. Consumer Services.

Previous companies

GlaxoSmithKline. UK. Health Care.

Glanbia. Ireland. Consumer Goods.

GKN. UK. Consumer Goods.

Gjensidige Forsikrin. Norway. Financials.

Givaudan N. Switzerland. Basic Materials.

Gilead Sciences. USA. Health Care.



All rights reserved

 information advertisement legal

Dividends Ranking | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.